Cheap cellphone-read test detects multiple TB immune signals

Tuberculosis control relies in part on tests that detect immune responses to TB antigens, especially to find people with latent TB infection (LTBI). The standard blood-based test called IGRA measures interferon gamma but needs sensitive laboratory equipment to detect the tiny amounts of signal released, which limits its use in resource-poor settings where TB is common. Recent studies have shown that looking at more than one cytokine, not just IFN-γ, can improve diagnostic accuracy, but measuring multiple cytokines usually requires even more expensive instruments. To address this gap, Aniruddh Sarkar and colleagues designed a low-cost, high-throughput platform for multiplexed cytokine detection that aims to work without specialized machines. The team turned to a printable, plastic format and a chemical amplification strategy called amplified enzymatic silver metallization to make immune signals visible. By performing the assay in simple microwells formed on a commonly available plastic petri dish and reading the result with a cellphone camera, they sought to reduce cost and complexity while keeping the sensitivity needed for TB diagnostics.

The new assay combines antibody-based capture of cytokines with amplified enzymatic silver metallization on a plastic substrate to produce a dry, visible deposit that can be imaged with a cellphone camera. The microwells are formed on a plastic petri dish, enabling a high-throughput layout without glass slides or expensive plates. Using this approach, the researchers demonstrated the ability to measure clinically relevant sub-picomolar levels of multiple cytokines, including IFN-γ, interleukin-2 (IL-2), and tumor necrosis factor alpha (TNF-α). They showed these tiny signals could be detected from a small volume (<5µL) of the same blood sample used in an IGRA, which minimizes extra sample needs. Finally, the team demonstrated the use of this assay to distinguish IGRA+ and IGRA-participant samples from a TB endemic setting, indicating the method can operate on real-world clinical specimens and provide multiplexed cytokine readouts without high-end laboratory detectors.

If the performance holds up beyond the initial study, this approach could change how cytokine-based TB diagnostics are done in low-resource environments. By coupling amplified enzymatic silver metallization with a plastic petri dish format and cellphone camera readout, the method avoids the expensive optical instruments that typically limit multiplexed assays. Detecting IFN-γ alongside other markers like interleukin-2 (IL-2) and tumor necrosis factor alpha (TNF-α) from the same tiny blood sample could improve the diagnostic information available from an IGRA-style test for LTBI. The low sample volume (<5µL) and dry, phone-readable silver deposits make the assay potentially compatible with high-throughput screening and point-of-care workflows in TB-endemic areas. While further validation and development would be needed, the study by Aniruddh Sarkar points to a practical route for bringing multiplexed cytokine detection closer to the clinics and communities that need it most.